Next Article in Journal
Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis
Next Article in Special Issue
Do All Patients Require Radiotherapy after Breast-Conserving Surgery?
Previous Article in Journal
Role of Inflammation and Oxidative Stress Mediators in Gliomas
Previous Article in Special Issue
Possible DNA Viral Factors of Human Breast Cancer
Open AccessArticle

A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer

1
Department of Breast Surgery, Kyoto University Hospital, 54 Kawara-cho Shogoin, Sakyo-ku Kyoto 606-8507, Japan
2
Surgical Oncology Department, South Egypt Cancer Institute, Assiut University, El-Methaq St., Mansheit El-Omara square, Assiut, Egypt
3
Department of Surgery, Shinko Hospital, 1-4-47, Wakihama-cho, Chuo-ku, Kobe 651-0072, Japan
4
Department of Surgery, Kobe City Medical Center General Hospital, 4-6 Minatojima Nakamachi Chuo-ku, Kobe 650-0046, Japan
*
Author to whom correspondence should be addressed.
Cancers 2010, 2(2), 713-720; https://doi.org/10.3390/cancers2020713
Received: 20 February 2010 / Revised: 14 April 2010 / Accepted: 22 April 2010 / Published: 27 April 2010
(This article belongs to the Special Issue Breast Cancer)
We investigated the feasibility of sentinel lymph node (SLN) biopsy using indocyanine green (ICG) technique in 411 patients with early breast cancer at three institutes. ICG, a fluorescence source, and blue dye were injected into the subareolar area to enable real-time image-guided surgery and identification of SLN fluorescence after meticulous dissection. The subcutaneous lymphatic channels were precisely detected in all cases. SLN identification rate was 99% (408/411) with a mean of 2.3 nodes identified per patient. Thirty-nine cases (9.5%) had SLNs involved and all of them were ICG positive. Thus, the ICG technique has a high SLN identification rate comparable with that of the radioisotope method. View Full-Text
Keywords: sentinel lymph node; indocyanine green (ICG); fluorescence; breast cancer sentinel lymph node; indocyanine green (ICG); fluorescence; breast cancer
Show Figures

Graphical abstract

MDPI and ACS Style

Sugie, T.; Kassim, K.A.; Takeuchi, M.; Hashimoto, T.; Yamagami, K.; Masai, Y.; Toi, M. A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer. Cancers 2010, 2, 713-720. https://doi.org/10.3390/cancers2020713

AMA Style

Sugie T, Kassim KA, Takeuchi M, Hashimoto T, Yamagami K, Masai Y, Toi M. A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer. Cancers. 2010; 2(2):713-720. https://doi.org/10.3390/cancers2020713

Chicago/Turabian Style

Sugie, Tomoharu; Kassim, Kassim Abdelazeem; Takeuchi, Megumi; Hashimoto, Takashi; Yamagami, Kazuhiko; Masai, Yoshikazu; Toi, Masakazu. 2010. "A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer" Cancers 2, no. 2: 713-720. https://doi.org/10.3390/cancers2020713

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop